ASP Announces Acquisition of Gloster Europe to Help Reduce Infections in Healthcare Facilities

New Area Decontamination Technology Broadens ASP's Portfolio of Infection Prevention Solutions by Providing Patients with Assurance that Their Hospital Environment is Disinfected

IRVINE, California, November 23 - Advanced Sterilization Products (ASP), a leading global infection
prevention solution provider, announced today the acquisition by its French
affiliate, Apsis S.A.S., of Gloster Europe, a privately held developer of
innovative disinfection processes and technologies to prevent
healthcare-acquired infections. Terms of the acquisition were not disclosed.

Gloster Europe designs and markets an innovative area decontamination
technology that provides disinfection of patient environments such as
hospital and operating rooms. This technology generates a dry mist of
hydrogen peroxide on all surfaces for broad and efficient disinfection.
Gloster Europe's products have gained significant momentum in Europe and the
Middle East and have achieved scientific recognition for their effectiveness
against superbugs, such as MRSA and C.difficile, as well as many other
viruses and fungi.

"Area decontamination technology is a perfect strategic complement to
ASP's existing portfolio of surgical instrument sterilization, high-level
disinfection and hand hygiene solutions," said Chuck Austin, Worldwide
President of ASP. "Healthcare-acquired infections are a growing global
concern. ASP is proud to offer patients who need hospital care greater peace
of mind, knowing their room has the added infection protection benefit of
this advanced and automated disinfection technology."

Never has the need been greater for novel area decontamination
technologies with healthcare-acquired infection rates rising across the
globe. Healthcare-acquired infections are at unacceptable rates with an
incidence of 4.5 percent of hospital admissions in the U.S. and Western
Europe and as high as 15 percent in emerging markets.(1)

Gloster Europe's technologies, marketed under the STERINIS(R) brand name,
are currently available in Europe, the Middle East and select countries in
Africa and Asia with rapid expansion to other markets planned for 2010 and
beyond, pending country-specific regulations.

About Advanced Sterilization Products (ASP)

Advanced Sterilization Products (ASP) division of Ethicon, Inc., a member
of the Johnson & Johnson Family of Companies, is a leading developer of
innovative instrument sterilization, high level disinfection and cleaning
technologies. The company is dedicated to protecting patients, healthcare
workers, and the environment with products that focus as much on safety as
they do on efficacy and cost-effectiveness. Utilizing advanced instrument
processing technologies, these products help customers to promote positive
patient outcomes while controlling costs, increasing productivity and
enhancing safety. The company is based in Irvine, California, with offices
around the world.

(c) Ethicon, Inc. 2009

(1) Centers of Disease Control and Prevention. Estimates on HealthCare
Associated Infections. Available at: www.cdc.gov/ncidod/dhqp/hai.html.
Accessed October 2007.

Media, U.S., Katie Sweet, +1-949-789-3945, ksweet at its.jnj.com, or EMEA, Teresa Mueller, +33-1-55-00-44-33, tmueller1 at its.jnj.com, both of ASP; or Investors, Stan Panasewicz, +1-732-524-2524, spanase1 at its.jnj.com, or Louise Mehrotra, +1-732-524-6491, lmehrot at its.jnj.com, both of Johnson & Johnson Investor Relations